Lipitor, Atorvastatin

Lipitor, Atorvastatin Newswire (Page 5)

Comprehensive Real-Time News Feed for Lipitor, Atorvastatin (generic). (Page 5)

Results 81 - 100 of 789 in Lipitor, Atorvastatin (generic)

  1. Statin standoff: Does rosuvastatin tip the balance in diabetic patients?Read the original story w/Photo

    Sep 2, 2014 | Medical News Today

    When it comes to cholesterol-lowering statin medications for patients with type 2 diabetes , rosuvastatin may be a better choice than atorvastatin , according to the findings of a new study presented at ESC Congress 2014.

    Comment?

  2. South Carolina Litigation Adds 200 Lipitor Lawsuits in a Month, as...Read the original story

    Sep 1, 2014 | Personal Injury Law News

    The Firm is evaluating potential Lipitor lawsuits on behalf of individuals who allegedly developed Lipitor diabetes injuries after taking the cholesterol-lowering statin drug.

    Comment?

  3. Biventricular pacing disappoints in BIOPACE trialRead the original story w/Photo

    Sep 1, 2014 | PhysOrg Weblog

    Biventricular pacing failed to significantly improve outcome compared to right ventricular pacing in patients with atrio-ventricular block according to preliminary results presented as a Hot Line at ESC Congress 2014.

    Comment?

  4. Experimental coronary stent combines ultrathin structure with biodegradable materialRead the original story w/Photo

    Sep 1, 2014 | PhysOrg Weblog

    A new generation of coronary artery stent that combines a biodegradable component with an ultrathin scaffold showed promising results compared with the current gold standard, in a large population of coronary artery disease patients, according to a new study.

    Comment?

  5. Investigational agent outshines ezetimibe for lowering cholesterolRead the original story w/Photo

    Sep 1, 2014 | PhysOrg Weblog

    The investigational drug alirocumab significantly improved cholesterol levels compared to ezetimibe, when added to regular statin therapy in patients with high cholesterol and elevated risk of cardiovascular disease , according to the ODYSSEY COMBO II trial, presented as a Hot Line today at ESC Congress 2014.

    Comment?

  6. New national guidelines can improve the way statin drugs are...Read the original story w/Photo

    Aug 29, 2014 | Medical News Today

    The research, recently published in the Journal of the American College of Cardiology , also showed the new guidelines produce only a modest increase in the number of patients being given the drugs.

    Comment?

  7. Amgen seeks approval for new cholesterol drugRead the original story

    Aug 28, 2014 | Pacific Business Times

    Amgen became the first drugmaker to seek U.S. regulatory approval for a new class of cholesterol-lowering treatments after it submitted an application to the Food and Drug Administration on Thursday for evolocumab.

    Comment?

  8. UPDATE 1-Amgen seeks U.S. approval of new cholesterol-fighting drugRead the original story

    Aug 28, 2014 | Reuters

    Amgen Inc said on Thursday it applied to U.S. health regulators to sell its cholesterol fighter, evolocumab, becoming the first company to seek approval of a medicine from a closely watched new class of potent heart drugs.

    Comment?

  9. Amgen Announces Positive Top-Line Results From Phase 3 YUKAWA-2 Trial ...Read the original story

    Aug 28, 2014 | Applied Clinical Trials

    Patients were randomized to one of eight treatment groups to compare subcutaneous evolocumab with subcutaneous placebo when added to different daily doses of atorvastatin.

    Comment?

  10. Amgen's Cholesterol Lowering Drug Succeeds In Phase 3 TrialRead the original story

    Aug 28, 2014 | BioSpace

    Amgen Announces Positive Top-Line Results From Phase 3 YUKAWA-2 Trial Of Evolocumab In Combination With Statins In Japanese Patients With High Cardiovascular Risk And High Cholesterol Study Meets Co-Primary Endpoints of LDL Cholesterol Reduction dvanced Cardiovascular Risk) study evaluating evolocumab in combination with statin therapy in Japanese ... (more)

    Comment?

  11. New statin guidelines an improvement, study showsRead the original story w/Photo

    Aug 26, 2014 | Science Daily

    New national guidelines can improve the way statin drugs are prescribed to patients at risk for cardiovascular disease, a study has found.

    Comment?

  12. New guidelines can improve the way statin drugs prescribed to patients at cardiovascular riskRead the original story w/Photo

    Aug 26, 2014 | Medical News

    New national guidelines can improve the way statin drugs are prescribed to patients at risk for cardiovascular disease , a Yale University study has found.

    Comment?

  13. New statin guidelines are an improvement, study showsRead the original story w/Photo

    Aug 26, 2014 | PhysOrg Weblog

    New national guidelines can improve the way statin drugs are prescribed to patients at risk for cardiovascular disease, a Yale University study has found.

    Comment?

  14. New statin guidelines are an improvement, Yale study showsRead the original story

    Aug 25, 2014 | PressReleasePoint

    New national guidelines can improve the way statin drugs are prescribed to patients at risk for cardiovascular disease, a Yale University study has found.

    Comment?

  15. New Statin Guidelines are an ImprovementRead the original story

    Aug 25, 2014 | Health News Digest

    New Haven, Conn.- New national guidelines can improve the way statin drugs are prescribed to patients at risk for cardiovascular disease, a Yale University study has found.

    Comment?

  16. Tonix Could Match Pfizer's Biggest Drug's Best MarketRead the original story

    Aug 22, 2014 | Seeking Alpha

    Tough Times After Lipitor Pfizer is one of the largest pharmaceutical companies in the world, but it has had a rough few years since its best selling drug Lipitor came off patent in 2011.

    Comment?

  17. Effect of High-Dose Atorvastatin on Renal Function in Subjects With...Read the original story

    Aug 21, 2014 | Circulation

    Department of Neurology and Stroke Center, Paris-Diderot Sorbonne University, Paris, France ; Department of Neurology, Vanderbilt University, Nashville, TN ; Division of Nephrology and Hypertension Center, USC/Keck School of Medicine, Los Angeles, CA ; Department of Neurology, Duke University Medical Center, Durham, NC ; Department of Neurology, ... (more)

    Comment?

  18. Speeding up the fight against Ebola, other diseasesRead the original story w/Photo

    Aug 21, 2014 | Boston.com

    For vaccines and treatments aimed at vanquishing infectious diseases, it's a long, bumpy road from the laboratory to the doctor's office, a journey that can take years and cost hundreds of millions of dollars - if it happens at all.

    Comment?

  19. KosAbility Upcoming ScheduleRead the original story w/Photo

    Aug 20, 2014 | Daily Kos

    MED GROUPS PROMO OUT OF THE DIARY AND INTO CUSTOMIZED TIPJAR WHEN READY TO PUBLISH, & DELETE THIS INSTRUCTION The HEALTH-MEDICAL & RELATED DK Groups KosAbility maintains this DIRECTORY as a longterm DK reference service project of about 25 daily-living-with-it groups focused on specific health concerns, and about 20 more on political, professional, ... (more)

    Comment?

  20. Contribution of Homeostatic Chemokines CCL19 and CCL21 and Their...Read the original story

    Aug 20, 2014 | Circulation

    Correspondence to Yaling Han, MD, PhD, Cardiovascular Research Institute and Department of Cardiology, Shenyang Northern Hospital, 83 Wenhua Rd, Shenyang 110840, China.

    Comment?